Médecins Sans Frontières, MSF, has warned that shortages of a lifesaving medicine are forcing medical teams to ration treatment for diphtheria patients in northern Nigeria, where more than 28,000 confirmed infections and 1,100 deaths have been reported this year.
The warning comes as figures attributed to the Nigeria Centre for Disease Control and Prevention, NCDC, show that the outbreak continues to spread, particularly among children who are unvaccinated or have not received all their recommended vaccine doses.
In a statement issued on Friday, MSF said supplies of diphtheria antitoxin (DAT), which neutralises the toxin responsible for potentially fatal complications, were dangerously low.
The organisation called on federal and state authorities, donors and international partners to urgently secure additional medicines and vaccines, ensure their timely clearance at ports and improve distribution to affected communities.
MSF’s Medical Coordinator in Nigeria, David Kizito, warned that the shortage could compromise the treatment of severely ill patients.
“Our stocks are dangerously low, and we risk being unable to treat children and save lives as the outbreak continues,” he said.
The warning comes amid a prolonged outbreak that began in late 2022.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the Nigerian Red Cross Society, citing NCDC data, indicates that Nigeria recorded 37,529 suspected diphtheria cases, 28,151 confirmed infections and 1,126 deaths in 2026 as of 7 November.
The report said the outbreak had affected 26 states and the Federal Capital Territory, covering 361 local government areas.